Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism SGLT1 inhibitors(Sodium/glucose cotransporter 1 inhibitors), SGLT2 inhibitors(Sodium/glucose cotransporter 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H20F4N2O6 |
InChIKeyIBAUCRODUSTJQW-MPZWGZMNSA-N |
CAS Registry702638-25-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 1 | France | - | |
Diabetes Mellitus, Type 2 | Phase 1 | - | - |